European Parliament Passes Cannabis Resolution, Joins WHO In Supporting Medical Marijuana

Following reports about the World Health Organization (WHO) recommending a rescheduling of cannabis and several of its key components under international drug treaties, the European Parliament voted on Wednesday on a resolution that would help advance medical cannabis in the countries that form the European Union.

While non-binding, the resolution seeks to incentivize European nations to increase access to medical marijuana, prioritizing scientific research and clinical studies. Same as the WHO’s recommendation, the European Parliament’s resolution shows how wide support for cannabis legalization is, but does not change any actual laws on the international or local levels.

“The EU Parliament is just the latest voice to recognize the medical value of cannabis and the benefits of regulation over prohibition,” Tom Angell, Forbes contributor and publisher of Marijuana Moment, told me. “I’m hopeful that the growing chorus in favor of reform will spur action by nations to change their policies and improve access for patients who need this medicine.”

The Details

After evaluating how the European Union could potentially support quality research in relation to marijuana-based medicines, establishing “standards for non-pharmaceutical medical cannabis to ensure consumer safety,” the members of the European Parliament voted on a resolution that calls on the Commission on use of cannabis for medicinal purposes and the states member of the European Union to “address the regulatory, financial and cultural barriers” that stunted scientific research on the cannabis and its medical uses.

In addition, the Commission and MEPs said it’s important to “define the conditions required to enable creditable, independent scientific research based on a wide range of material to be conducted into the use of cannabis for medicinal purposes.”